导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.79% | 174/1050 |
| 近一周 | -1.01% | 126/1104 |
| 近一月 | -7.96% | 914/1102 |
| 近一季 | -14.65% | 832/1092 |
| 近半年 | 11.40% | 230/1070 |
| 近一年 | 48.68% | 80/1018 |
| 近两年 | 184.96% | 69/926 |
| 近三年 | 159.79% | 50/834 |
| 成立以来 | 182.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.70% 119/1070 |
54.91% 201/1101 |
- - |
- - |
| 2025 | 70.91% 59/1065 |
4.20% 462/1014 |
6.47% 216/1038 |
40.23% 190/1050 |
9.86% 47/1065 |
| 2024 | 25.44% 48/1011 |
-2.68% 457/960 |
4.47% 119/983 |
9.88% 627/991 |
12.28% 46/1011 |
| 2023 | -16.20% 572/952 |
1.12% 566/880 |
-3.05% 380/895 |
-13.52% 740/915 |
-1.16% 175/952 |
| 2022 | -31.67% 659/867 |
-27.26% 731/773 |
11.33% 214/806 |
-9.82% 235/845 |
-6.43% 682/867 |
| 2021 | 15.69% 186/740 |
-5.93% 383/580 |
15.38% 229/659 |
-1.94% 251/704 |
8.70% 110/740 |
| 2020 | 84.84% 76/554 |
-1.95% 215/419 |
41.59% 18/466 |
9.45% 264/517 |
21.65% 105/554 |
| 2019 | 57.93% 91/410 |
33.50% 197/1149 |
-3.03% 583/1231 |
13.88% 57/390 |
7.14% 268/410 |
| 2018 | -40.00% 277/349 |
- - |
- - |
- - |
-13.45% 785/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银智能制造股票A VS. 东吴新产业精选股票A(580008) |